Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ATI Physical Therapy, Inc.ATIP · Entity 79823 | Director · 10% owner | January 30, 2024 | February 08, 2024 |
| John Hancock Marathon Asset-Based Lending FundNA · Entity 19949 | Officer of Sub-Advisor | November 03, 2025 | August 13, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ATI Physical Therapy, Inc.
Report date January 30, 2024 · Filed February 08, 2024
Jointly reported with MARATHON ASSET MANAGEMENT LP, Marathon Asset Management GP, L.L.C., MARATHON DISTRESSED CREDIT MASTER FUND, MCSP Sub, LLC, MARATHON STEPSTONE MASTER FUND LP, Richards Bruce J
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Series B Preferred StockSEC Table I · non-derivative | IndirectSee Footnote | 49,725 |
Reported balance
After 2024-01-30 transaction · row 1
Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes.
1 source rowRow 1 · 2024-01-30 · Grant · Acquired 8,000 · Balance 49,725 F1: Reflects the issuance of shares of Series B Preferred Stock by the Issuer to the Marathon Funds (as defined below) on January 30, 2024 in connection with the issuance of the Delayed Draw Notes (as described below) in accordance with the terms of that certain Note Purchase Agreement, dated as of April 17, 2023 (as subsequently amended (the "NPA"). F6: Marathon Asset Management, L.P. ("Marathon"), as the investment manager of each of MAM PT, LLC ("MAM"), MCSP SUB LLC ("Empire"), Marathon Distressed Credit Master Fund ("MDCF") and Marathon Stepstone Master Fund LP ("StepStone" and, together with MAM, Empire, MDCF, the "Marathon Funds"), has the sole power to vote and direct the disposition of all the reported securities held by the Marathon Funds. Accordingly, Marathon may be deemed to beneficially own such reported securities. The general partner of Marathon is Marathon Asset Management GP, L.L.C. Bruce Richards and Louis Hanover are the managing members of Marathon Asset Management GP, L.L.C. and, thus, may be deemed to beneficially own the reported securities held by the Marathon Funds. This report is not an admission that any Reporting Person beneficially owns the reported securities. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. |
| Convertible PIK Notes (Delayed Draw)SEC Table II · derivative / convertible security | IndirectSee Footnote | 640,000 |
Reported balance
After 2024-01-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-01-30 · Grant · Acquired 640,000 · Balance 640,000 F3: Subject to earlier conversion in accordance with their terms, the Delayed Draw Notes will become due and payable on August 24, 2028 (the "Maturity Date") in an amount equal to the principal amount of the Delayed Draw Notes outstanding on such date (plus any accrued but unpaid interest thereon). F4: All or any portion of the Delayed Draw Notes may be converted at the election of the Reporting Persons at any time prior to the close of business on the business day immediately preceding the Maturity Date into a number of shares of Common Stock of the Issuer, determined by dividing (a) the outstanding balance of the principal amount of the Notes being converted (together with the accrued but unpaid interest thereon) as of the applicable conversion date, by (b) a conversion price of $12.50, which such conversion price is subject to certain anti-dilution adjustments in accordance with the terms of the NPA. F2: Reflects the issuance of senior second lien convertible PIK delayed draw notes (the "Delayed Draw Notes") by the Issuer to the Marathon Funds on January 30, 2024. The aggregate principal amount of the Delayed Draw Notes is $8,000,000, and the Delayed Draw Notes accrue interest at a rate of 8.00% per annum. F5: This number represents the number of shares of Common Stock issuable upon conversion of the Delayed Draw Notes if the Reporting Persons elect to convert the Delayed Draw Notes based on the principal amount of the Delayed Draw Notes (as described in footnote 2 above) and the conversion price (as described in footnote 4 above). F6: Marathon Asset Management, L.P. ("Marathon"), as the investment manager of each of MAM PT, LLC ("MAM"), MCSP SUB LLC ("Empire"), Marathon Distressed Credit Master Fund ("MDCF") and Marathon Stepstone Master Fund LP ("StepStone" and, together with MAM, Empire, MDCF, the "Marathon Funds"), has the sole power to vote and direct the disposition of all the reported securities held by the Marathon Funds. Accordingly, Marathon may be deemed to beneficially own such reported securities. The general partner of Marathon is Marathon Asset Management GP, L.L.C. Bruce Richards and Louis Hanover are the managing members of Marathon Asset Management GP, L.L.C. and, thus, may be deemed to beneficially own the reported securities held by the Marathon Funds. This report is not an admission that any Reporting Person beneficially owns the reported securities. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. |
| Series A Preferred StockSEC Table I · non-derivative | IndirectSee Footnote | 50,000 |
Reported balance
Holding disclosure · report date 2024-01-30 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 50,000 F6: Marathon Asset Management, L.P. ("Marathon"), as the investment manager of each of MAM PT, LLC ("MAM"), MCSP SUB LLC ("Empire"), Marathon Distressed Credit Master Fund ("MDCF") and Marathon Stepstone Master Fund LP ("StepStone" and, together with MAM, Empire, MDCF, the "Marathon Funds"), has the sole power to vote and direct the disposition of all the reported securities held by the Marathon Funds. Accordingly, Marathon may be deemed to beneficially own such reported securities. The general partner of Marathon is Marathon Asset Management GP, L.L.C. Bruce Richards and Louis Hanover are the managing members of Marathon Asset Management GP, L.L.C. and, thus, may be deemed to beneficially own the reported securities held by the Marathon Funds. This report is not an admission that any Reporting Person beneficially owns the reported securities. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the issuance of shares of Series B Preferred Stock by the Issuer to the Marathon Funds (as defined below) on January 30, 2024 in connection with the issuance of the Delayed Draw Notes (as described below) in accordance with the terms of that certain Note Purchase Agreement, dated as of April 17, 2023 (as subsequently amended (the "NPA").
F2: Reflects the issuance of senior second lien convertible PIK delayed draw notes (the "Delayed Draw Notes") by the Issuer to the Marathon Funds on January 30, 2024. The aggregate principal amount of the Delayed Draw Notes is $8,000,000, and the Delayed Draw Notes accrue interest at a rate of 8.00% per annum.
F3: Subject to earlier conversion in accordance with their terms, the Delayed Draw Notes will become due and payable on August 24, 2028 (the "Maturity Date") in an amount equal to the principal amount of the Delayed Draw Notes outstanding on such date (plus any accrued but unpaid interest thereon).
F4: All or any portion of the Delayed Draw Notes may be converted at the election of the Reporting Persons at any time prior to the close of business on the business day immediately preceding the Maturity Date into a number of shares of Common Stock of the Issuer, determined by dividing (a) the outstanding balance of the principal amount of the Notes being converted (together with the accrued but unpaid interest thereon) as of the applicable conversion date, by (b) a conversion price of $12.50, which such conversion price is subject to certain anti-dilution adjustments in accordance with the terms of the NPA.
F5: This number represents the number of shares of Common Stock issuable upon conversion of the Delayed Draw Notes if the Reporting Persons elect to convert the Delayed Draw Notes based on the principal amount of the Delayed Draw Notes (as described in footnote 2 above) and the conversion price (as described in footnote 4 above).
F6: Marathon Asset Management, L.P. ("Marathon"), as the investment manager of each of MAM PT, LLC ("MAM"), MCSP SUB LLC ("Empire"), Marathon Distressed Credit Master Fund ("MDCF") and Marathon Stepstone Master Fund LP ("StepStone" and, together with MAM, Empire, MDCF, the "Marathon Funds"), has the sole power to vote and direct the disposition of all the reported securities held by the Marathon Funds. Accordingly, Marathon may be deemed to beneficially own such reported securities. The general partner of Marathon is Marathon Asset Management GP, L.L.C. Bruce Richards and Louis Hanover are the managing members of Marathon Asset Management GP, L.L.C. and, thus, may be deemed to beneficially own the reported securities held by the Marathon Funds. This report is not an admission that any Reporting Person beneficially owns the reported securities. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
John Hancock Marathon Asset-Based Lending Fund
Report date November 03, 2025 · Filed August 13, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class I SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2025-11-03 transaction · row 1
1 source rowRow 1 · 2025-11-03 · Gift · Disposed 431,876.15 · Balance 0 F1: Reflects the transfer of Class I Shares by the Reporting Person to a charitable trust in exchange for no payment. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the transfer of Class I Shares by the Reporting Person to a charitable trust in exchange for no payment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 03, 2025 Filed Aug 13, 2026 20:15 UTC | John Hancock Marathon Asset-Based Lending Fund NA · Entity 19949 | GiftClass I Shares | 431,876.15 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-037777 · ownership.xml · nonDerivative · entry 1 Hanover Louis · CIK 0001939267 · Officer of Sub-Advisor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects the transfer of Class I Shares by the Reporting Person to a charitable trust in exchange for no payment. F1 · shares: Reflects the transfer of Class I Shares by the Reporting Person to a charitable trust in exchange for no payment. F1 · price: Reflects the transfer of Class I Shares by the Reporting Person to a charitable trust in exchange for no payment. Read SEC document |
| November 29, 2024 Filed Aug 14, 2025 21:05 UTC | John Hancock Marathon Asset-Based Lending Fund NA · Entity 19949 | OtherClass I Shares | 295,130.35 | $0.00 | $0.00 |
DisclosureSEC source: 0001641172-25-024160 · ownership.xml · nonDerivative · entry 1 Hanover Louis · CIK 0001939267 · Officer of Sub-Advisor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 431,876.15 F1 · kind: Reflects the transfer of Class I Shares by Marathon Asset Management, L.P., the Sub-Advisor of the Issuer (the "Sub-Advisor"), to the Reporting Person as a limited partner of the Sub-Advisor in exchange for no payment. F1 · shares: Reflects the transfer of Class I Shares by Marathon Asset Management, L.P., the Sub-Advisor of the Issuer (the "Sub-Advisor"), to the Reporting Person as a limited partner of the Sub-Advisor in exchange for no payment. F1 · price: Reflects the transfer of Class I Shares by Marathon Asset Management, L.P., the Sub-Advisor of the Issuer (the "Sub-Advisor"), to the Reporting Person as a limited partner of the Sub-Advisor in exchange for no payment. Read SEC document |
| October 22, 2024 Filed Dec 13, 2024 22:15 UTC | John Hancock Marathon Asset-Based Lending Fund NA · Entity 19949 | OtherClass I Shares | 136,745.8 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-24-050031 · ownership.xml · nonDerivative · entry 1 Hanover Louis · CIK 0001939267 · Officer of Sub-Advisor 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 136,745.8 F1 · kind: Reflects the transfer of Class I Shares by Marathon Asset Management, L.P., the Sub-Advisor of the Issuer (the "Sub-Advisor"), to the Reporting Person as a limited partner of the Sub-Advisor in exchange for no payment. F1 · shares: Reflects the transfer of Class I Shares by Marathon Asset Management, L.P., the Sub-Advisor of the Issuer (the "Sub-Advisor"), to the Reporting Person as a limited partner of the Sub-Advisor in exchange for no payment. F1 · price: Reflects the transfer of Class I Shares by Marathon Asset Management, L.P., the Sub-Advisor of the Issuer (the "Sub-Advisor"), to the Reporting Person as a limited partner of the Sub-Advisor in exchange for no payment. Read SEC document |
| January 30, 2024 Filed Feb 8, 2024 19:06 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantConvertible PIK Notes (Delayed Draw) · Derivative | 640,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950103-24-001958 · dp206546_4-marathon.xml · derivative · entry 3 MARATHON ASSET MANAGEMENT LP · CIK 0001279913 · Director · 10% owner Marathon Asset Management GP, L.L.C. · CIK 0001983009 · Director · 10% owner MARATHON DISTRESSED CREDIT MASTER FUND · CIK 0001920239 · Director · 10% owner MCSP Sub, LLC · CIK 0001983012 · Director · 10% owner MARATHON STEPSTONE MASTER FUND LP · CIK 0001920234 · Director · 10% owner Richards Bruce J · CIK 0001983069 · Director · 10% owner Hanover Louis · CIK 0001939267 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 640,000 Underlying: Class A Common Stock · 640,000 shares Expires not disclosed F3 · derivative.exercise_price: Subject to earlier conversion in accordance with their terms, the Delayed Draw Notes will become due and payable on August 24, 2028 (the "Maturity Date") in an amount equal to the principal amount of the Delayed Draw Notes outstanding on such date (plus any accrued but unpaid interest thereon). F4 · derivative.exercise_price: All or any portion of the Delayed Draw Notes may be converted at the election of the Reporting Persons at any time prior to the close of business on the business day immediately preceding the Maturity Date into a number of shares of Common Stock of the Issuer, determined by dividing (a) the outstanding balance of the principal amount of the Notes being converted (together with the accrued but unpaid interest thereon) as of the applicable conversion date, by (b) a conversion price of $12.50, which such conversion price is subject to certain anti-dilution adjustments in accordance with the terms of the NPA. F2 · kind: Reflects the issuance of senior second lien convertible PIK delayed draw notes (the "Delayed Draw Notes") by the Issuer to the Marathon Funds on January 30, 2024. The aggregate principal amount of the Delayed Draw Notes is $8,000,000, and the Delayed Draw Notes accrue interest at a rate of 8.00% per annum. F2 · shares: Reflects the issuance of senior second lien convertible PIK delayed draw notes (the "Delayed Draw Notes") by the Issuer to the Marathon Funds on January 30, 2024. The aggregate principal amount of the Delayed Draw Notes is $8,000,000, and the Delayed Draw Notes accrue interest at a rate of 8.00% per annum. F5 · shares: This number represents the number of shares of Common Stock issuable upon conversion of the Delayed Draw Notes if the Reporting Persons elect to convert the Delayed Draw Notes based on the principal amount of the Delayed Draw Notes (as described in footnote 2 above) and the conversion price (as described in footnote 4 above). F2 · price: Reflects the issuance of senior second lien convertible PIK delayed draw notes (the "Delayed Draw Notes") by the Issuer to the Marathon Funds on January 30, 2024. The aggregate principal amount of the Delayed Draw Notes is $8,000,000, and the Delayed Draw Notes accrue interest at a rate of 8.00% per annum. F3 · derivative.exercise_date: Subject to earlier conversion in accordance with their terms, the Delayed Draw Notes will become due and payable on August 24, 2028 (the "Maturity Date") in an amount equal to the principal amount of the Delayed Draw Notes outstanding on such date (plus any accrued but unpaid interest thereon). F4 · derivative.exercise_date: All or any portion of the Delayed Draw Notes may be converted at the election of the Reporting Persons at any time prior to the close of business on the business day immediately preceding the Maturity Date into a number of shares of Common Stock of the Issuer, determined by dividing (a) the outstanding balance of the principal amount of the Notes being converted (together with the accrued but unpaid interest thereon) as of the applicable conversion date, by (b) a conversion price of $12.50, which such conversion price is subject to certain anti-dilution adjustments in accordance with the terms of the NPA. F3 · derivative.expiration_date: Subject to earlier conversion in accordance with their terms, the Delayed Draw Notes will become due and payable on August 24, 2028 (the "Maturity Date") in an amount equal to the principal amount of the Delayed Draw Notes outstanding on such date (plus any accrued but unpaid interest thereon). F4 · derivative.expiration_date: All or any portion of the Delayed Draw Notes may be converted at the election of the Reporting Persons at any time prior to the close of business on the business day immediately preceding the Maturity Date into a number of shares of Common Stock of the Issuer, determined by dividing (a) the outstanding balance of the principal amount of the Notes being converted (together with the accrued but unpaid interest thereon) as of the applicable conversion date, by (b) a conversion price of $12.50, which such conversion price is subject to certain anti-dilution adjustments in accordance with the terms of the NPA. F2 · derivative.underlying_shares: Reflects the issuance of senior second lien convertible PIK delayed draw notes (the "Delayed Draw Notes") by the Issuer to the Marathon Funds on January 30, 2024. The aggregate principal amount of the Delayed Draw Notes is $8,000,000, and the Delayed Draw Notes accrue interest at a rate of 8.00% per annum. F5 · derivative.underlying_shares: This number represents the number of shares of Common Stock issuable upon conversion of the Delayed Draw Notes if the Reporting Persons elect to convert the Delayed Draw Notes based on the principal amount of the Delayed Draw Notes (as described in footnote 2 above) and the conversion price (as described in footnote 4 above). F5 · balance_after: This number represents the number of shares of Common Stock issuable upon conversion of the Delayed Draw Notes if the Reporting Persons elect to convert the Delayed Draw Notes based on the principal amount of the Delayed Draw Notes (as described in footnote 2 above) and the conversion price (as described in footnote 4 above). F6 · ownership.nature: Marathon Asset Management, L.P. ("Marathon"), as the investment manager of each of MAM PT, LLC ("MAM"), MCSP SUB LLC ("Empire"), Marathon Distressed Credit Master Fund ("MDCF") and Marathon Stepstone Master Fund LP ("StepStone" and, together with MAM, Empire, MDCF, the "Marathon Funds"), has the sole power to vote and direct the disposition of all the reported securities held by the Marathon Funds. Accordingly, Marathon may be deemed to beneficially own such reported securities. The general partner of Marathon is Marathon Asset Management GP, L.L.C. Bruce Richards and Louis Hanover are the managing members of Marathon Asset Management GP, L.L.C. and, thus, may be deemed to beneficially own the reported securities held by the Marathon Funds. This report is not an admission that any Reporting Person beneficially owns the reported securities. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. Read SEC document |
| January 30, 2024 Filed Feb 8, 2024 19:06 UTC | ATI Physical Therapy, Inc. ATIP · Entity 79823 | GrantSeries B Preferred Stock | 8,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950103-24-001958 · dp206546_4-marathon.xml · nonDerivative · entry 1 MARATHON ASSET MANAGEMENT LP · CIK 0001279913 · Director · 10% owner Marathon Asset Management GP, L.L.C. · CIK 0001983009 · Director · 10% owner MARATHON DISTRESSED CREDIT MASTER FUND · CIK 0001920239 · Director · 10% owner MCSP Sub, LLC · CIK 0001983012 · Director · 10% owner MARATHON STEPSTONE MASTER FUND LP · CIK 0001920234 · Director · 10% owner Richards Bruce J · CIK 0001983069 · Director · 10% owner Hanover Louis · CIK 0001939267 · Director · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 49,725 F1 · kind: Reflects the issuance of shares of Series B Preferred Stock by the Issuer to the Marathon Funds (as defined below) on January 30, 2024 in connection with the issuance of the Delayed Draw Notes (as described below) in accordance with the terms of that certain Note Purchase Agreement, dated as of April 17, 2023 (as subsequently amended (the "NPA"). F1 · shares: Reflects the issuance of shares of Series B Preferred Stock by the Issuer to the Marathon Funds (as defined below) on January 30, 2024 in connection with the issuance of the Delayed Draw Notes (as described below) in accordance with the terms of that certain Note Purchase Agreement, dated as of April 17, 2023 (as subsequently amended (the "NPA"). F1 · price: Reflects the issuance of shares of Series B Preferred Stock by the Issuer to the Marathon Funds (as defined below) on January 30, 2024 in connection with the issuance of the Delayed Draw Notes (as described below) in accordance with the terms of that certain Note Purchase Agreement, dated as of April 17, 2023 (as subsequently amended (the "NPA"). F6 · ownership.nature: Marathon Asset Management, L.P. ("Marathon"), as the investment manager of each of MAM PT, LLC ("MAM"), MCSP SUB LLC ("Empire"), Marathon Distressed Credit Master Fund ("MDCF") and Marathon Stepstone Master Fund LP ("StepStone" and, together with MAM, Empire, MDCF, the "Marathon Funds"), has the sole power to vote and direct the disposition of all the reported securities held by the Marathon Funds. Accordingly, Marathon may be deemed to beneficially own such reported securities. The general partner of Marathon is Marathon Asset Management GP, L.L.C. Bruce Richards and Louis Hanover are the managing members of Marathon Asset Management GP, L.L.C. and, thus, may be deemed to beneficially own the reported securities held by the Marathon Funds. This report is not an admission that any Reporting Person beneficially owns the reported securities. Each Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.